FOXC2 regulates CYP1B1 transcription and activates the TGF-β/Smad pathway to promote pulmonary fibrosis
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Wei Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 42…. Hauptthemen laut MEDLINE: Forkhead Transcription Factors, Pulmonary Fibrosis, Smad Proteins, Cytochrome P-450 CYP1B1. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) is a progressive and fatal interstitial lung disease, with unclear pathogenesis and limited therapeutic options. Here, we investigated the role and mechanism of forkhead box C2 (FOXC2) in pulmonary fibrosis. The results showed that FOXC2 expression was significantly upregulated in lung tissues of mice with bleomycin (BLM)-induced pulmonary fibrosis. In vitro experiments demonstrated that knockdown of FOXC2 inhibited transforming growth factor-β1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) in A549 alveolar epithelial cells, reduced cell migration and invasion, and suppressed the activation of the TGF-β/Smad signaling pathway. Mechanistically, FOXC2 could bind to the promoter of cytochrome P450 1B1 (CYP1B1) to regulate its transcriptional activation. Knockdown of CYP1B1 exerted similar inhibitory effects on EMT and the TGF-β/Smad pathway to FOXC2 knockdown, while overexpression of CYP1B1 reversed the inhibitory effect of FOXC2 knockdown on TGF-β1-induced EMT. In vivo experiments confirmed that downregulation of FOXC2 attenuated BLM-induced pulmonary fibrosis in mice, which was associated with reduced CYP1B1 expression and inhibited activation of the TGF-β/Smad pathway. Collectively, these findings suggest that FOXC2 promotes pulmonary fibrosis by regulating CYP1B1 transcription and activating the TGF-β/Smad pathway, providing a potential therapeutic target for pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China.
- Department of Cardiovascular Medicine, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Key Laboratory of Heart Failure Prevention and Treatment of Hengyang, Clinical Medicine Research…
Zitieren
APA
Chen, W., Peng, J., Tang, X., Xiao, Y., Chen, Y., Tang, L., & Ouyang, S. (2026). FOXC2 regulates CYP1B1 transcription and activates the TGF-β/Smad pathway to promote pulmonary fibrosis. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112445
Vancouver
Chen W, Peng J, Tang X, Xiao Y, Chen Y, Tang L, et al. FOXC2 regulates CYP1B1 transcription and activates the TGF-β/Smad pathway to promote pulmonary fibrosis. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112445
BibTeX
@article{Chen2026,
author = {Chen, Wei and Peng, Jie and Tang, Xiangyi and Xiao, Yuting and Chen, Yi and Tang, Liangjun and Ouyang, Shao},
title = {FOXC2 regulates CYP1B1 transcription and activates the TGF-β/Smad pathway to promote pulmonary fibrosis},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112445}
}
EUVIMED